Adiponectin serum level is an independent and incremental predictor of all‐cause mortality after transcatheter aortic valve replacement-Reference-Cited by-同舟云学术

Adiponectin serum level is an independent and incremental predictor of all‐cause mortality after transcatheter aortic valve replacement

Published:2022-08-06 Issue:10 Volume:45 Page:1060-1069
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Walpot Jeroen¹²^ORCID,van Herck Paul¹,Collas Valerie³,Bossaerts Liene⁴,Van de Heyning Caroline M.¹³^ORCID,Vandendriessche Tom¹,Heidbuchel Hein¹³,Rodrigus Inez⁵,De Block Christophe⁶,Small Gary R.⁷,Bosmans Johan¹⁴

Affiliation:

1. Department of Cardiology University Hospital Antwerp Edegem Antwerp Belgium

2. Department of Cardiology ZorgSaam Hospital Terneuzen The Netherlands

3. Faculty of Health Sciences and Medicine University of Antwerp Wilrijk Belgium

4. Faculty of Biomedical Sciences University of Antwerp Wilrijk Belgium

5. Department of Cardiac Surgery University Hospital Antwerp Antwerp Edegem Belgium

6. Department of Endocrinology‐Diabetology and Metabolism Antwerp University Hospital Edegem Antwerp Belgium

7. Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23892

Reference32 articles.

1. 2017 ESC/EACTS Guidelines for the management of valvular heart disease

2. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients

3. Does EuroSCORE work in individual European countries?

4. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Part 2—Isolated Valve Surgery

5. Impact of frailty markers on outcomes after transcatheter aortic valve replacement: insights from a Japanese multicenter registry

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour necrosis factor-alpha serum level is an independent predictor of medium-term all-cause mortality after transcatheter aortic valve replacement;Acta Cardiologica;2024-02-07